Featured News

Bridging Innovation and Application in AI-Driven Precision Medicine

Precision medicine is no longer a distant ambition—it’s a field rapidly unfolding thanks to innovations in artificial intelligence (AI) and digital health. Today, clinicians can...

Real Chemistry Strengthens Presence in Europe with Key Leadership Moves

Camilla Griffiths named President of 21GRAMS Europe; Mike Nelson relocated to London as President, Integrated Communications, in new International Client Development role for Real Chemistry...

Beyond the Feed: How TikTok is Re-Shaping Media and Brand Strategy

TikTok is reshaping media and brand strategy by driving cultural trends, necessitating a shift towards social-first, creator-led content that is short, engaging, and authentic, especially...

Six Steps for Pharma Brands to Navigate the Fragmented Media Landscape

In today's rapidly evolving media landscape, pharma brands face an unprecedented challenge: effectively reaching consumers, patients and healthcare providers (HCPs) amid an overwhelming array of...

One Year Later: A Bold Step Forward for Medical Communications

Real Chemistry is known for its 20-year history of staying ahead of client needs, driving innovation throughout healthcare communications, and empowering our people. A year...

Real Chemistry Deepens Leadership Bench with Industry Elites Jeff Lupinacci and Julia Gaebler, Ph.D.

Lupinacci will serve as the company’s new chief financial officer while Gaebler will assume the newly created role of president of market access NEW YORK...

[Report] Navigating the New Political Landscape at JPM 2025

With tech and other industries actively aligning with the incoming administration, how are healthcare companies navigating the evolving political landscape — and how did that...

What Revisions to the Declaration of Helsinki Mean to Healthcare Marketers

By day I work with study sponsors on communication around clinical trials to accelerate recruitment and increase retention. Lately, in off hours, I find myself...

Which State Medicaid Programs Cover GLP-1s for Weight Loss & How Much Are They Spending?

This report was last updated Jan. 2, 2025. The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound...

…

6

…